Skip to main content
OpenTrials

Clinical trial condition

Carcinoid

Explore clinical trials studying Carcinoid. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Carcinoid trial results

Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

NCT07087054

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Intestine Tumor, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Yale University - New Haven Hospital - Yale Cancer Center New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 51 locations
View Trial Details
Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

NCT07165132

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations
  • Research Facility Iowa City, Iowa, United States
  • Research Facility Lexington, Kentucky, United States
  • Research Facility St Louis, Missouri, United States
  • Research Facility St Louis, Missouri, United States
View Trial Details
Recruiting

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

NCT05477576

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
Locations
  • Research Facility Phoenix, Arizona, United States
  • Research Facility Duarte, California, United States
  • Research Facility Irvine, California, United States
  • Research Facility Los Angeles, California, United States
View all 54 locations
View Trial Details
Completed

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

NCT05361668

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Intestine Tumor, +19 more
Locations
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Los Angeles, California, United States
  • Crinetics Study Site Newport Beach, California, United States
  • Crinetics Study Site Stanford, California, United States
View all 35 locations
View Trial Details
Completed

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

NCT01327612

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
Locations
  • Research Site Duarte, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Tampa, Florida, United States
View Trial Details
Completed

EPO906 in Carcinoid and Other Neuroendocrine Tumors

NCT00050349

Conditions
Adenocarcinoma, Carcinoid, Carcinoid Tumor, +23 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • University of Iowa Health Care Iowa City, Iowa, United States
  • LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2) New Orleans, Louisiana, United States
  • Weill Medical College of Cornell Univ. New York, United States
View Trial Details

Related conditions